Use of intermittently scanned continuous glucose monitoring in young people with high-risk type 1 diabetes - extension phase outcomes following a 6-month randomised control trial.
Shelley RoseSara E StylesEsko J WiltshireJames StanleyBarbara C GallandMartin I de BockPaul A TomlinsonJenny A RaynsKaren E MacKenzieBenjamin J WheelerPublished in: Diabetic medicine : a journal of the British Diabetic Association (2021)
The use of isCGM in young people with high-risk T1D resulted in transient improvements in HbA1c and glucose monitoring over a 9-month timeframe; however, benefits were not sustained to 12 months.